Corin Group acquire Belgium & Luxemburg large joint business unit of MBA NV

18 October 2017

Corin Group, after the successful acquisition of the Tornier Hip and Knee business is announcing a further European expansion by acquiring the large joint business unit of MBA Belgium & Luxemburg NV.

Over the last 7 years MBA has successfully distributed the Corin portfolio. The team have gone from strength to strength, expanding and developing solid collaborative relationships with key surgeons throughout the countries. The combination of Corin technologies and the MBA team’s passion for orthopaedics will deliver greater value to the Belgium and Luxemburg Orthopaedic community.

Stefano Alfonsi, Chief Executive Officer of Corin commented “With MBA’s, responsive service and solid working relationships they are well placed to engage their attentive audience with Corin’s world leading innovative technologies. We are delighted to welcome the team who are transitioning to Corin from MBA and look forward to building an even stronger surgeon focused organisation.”

Paul Griffin, International Business Director, MBA, commented, “Building on MBA’s success in Belgium & Luxemburg in the recent past,  Corin’s involvement will streamline the representation from MBA and Tornier to a single Corin entity, simplifying the customer experience, and enabling more surgeons to engage with Corin’s Ecosystem of  ground breaking technologies’.”    

About Corin

Since its inception, Corin has led the way in orthopaedic innovation — providing a faster, positive and more assured return to quality of life for people all over the world. Today, as a dynamic, growing, global business, Corin’s approach is revolutionising orthopaedics.

We offer a unique combination of clinically-proven hip, knee, ankle and shoulder solutions and world-leading technologies that enable patients, surgeons and healthcare providers to connect more closely than ever.

The deep insight we gain, understand and share at every stage of the connected orthopaedic experience leads to advanced, patient-specific solutions that exceed expectations, maximise value in healthcare and positively impact lives.

About MBA

MBA is a leading company in the European medical and surgical technology field. Our objective is to create value for the specialist through technology, service and sharing knowledge.

MBA currently has two divisions:

MBA

The Company began by specialising in providing complete solutions for Orthopaedic and Neurosurgeons via a full range of product lines for the following specialities:

• Knee
• Hip
• Shoulder
• Other joints: Elbow, Hand, Wrist, Foot and Ankle.
• Tumour and Extremity Reconstruction
• Biomaterials
• Spine
• Trauma

BIOSER

This Division provides solutions for nine surgical specialties: Anaesthesiology, General Surgery, Cardiovascular Surgery, Thoracic surgery, Urology, Gynaecology, Obstetrics, ENT, Plastic Surgery and Emergency Medicine.